Brief: Fibrobiologics Announces Positive IND-Enabling Updates Demonstrating Potential Of Fibroblast Spheroids In Chronic-Relapse Psoriasis Treatment
11/09/2025 15:09
Sept 11 (Reuters) - Fibrobiologics Inc FBLG.O: FIBROBIOLOGICS ANNOUNCES POSITIVE IND-ENABLING UPDATES DEMONSTRATING POTENTIAL OF FIBROBLAST SPHEROIDS IN CHRONIC-RELAPSE PSORIASIS TREATMENT Source text: ID:nGNX83p2Sm Further company coverage: FBLG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fibrobiologics
See all newsBrief: Fibrobiologics Files Patent Application For Technology Designed To Produce Glp-1 And Other Therapeutic Peptides Inside The Body
Brief: Fibrobiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair In Preclinical Study Of Degenerative Joints
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Brief: Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts